Skip to content

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02696096
Enrollment
21
Registered
2016-03-02
Start date
2016-08-31
Completion date
2020-02-29
Last updated
2022-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Addiction

Brief summary

This study proposes to use functional magnetic resonance imaging (FMRI) to observe brain activity and behavior associated with decision-making about rewards (DD task), working memory and working memory cognitive persistence (WM task), and craving (CR task) in 72 opiate dependent participants initiating buprenorphine. While stably using opiates (initial study appointment) and again during withdrawal (approximately 3 days later), participants will receive an FMRI scan with behavioral challenges; immediately after the second FMRI, they will receive their first dose of buprenorphine. Buprenorphine treatment will continue for twelve weeks, followed by a four week taper. Urine toxicological analysis will be performed prior to the first scanning session, weekly for two weeks and biweekly thereafter. Participation for all individuals will last 4 months. Assessments will occur at baseline, and weeks 1, 2, 4, 8, and 12. Buprenorphine induction will begin at the completion of the second scan; follow-up medical visits will align with study assessments on weeks 1, 2, 4, 8 and 12. All participants will receive 16 weeks of buprenorphine (the final 4 of these 16 weeks will include a taper).

Interventions

OTHERFMRI

all participants will complete 2 FMRIs

all participants will be prescribed Suboxone for 4 months during their study participation

Sponsors

Butler Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* opiate dependent persons * 21-50 years old * interested in initiating outpatient buprenorphine treatment

Exclusion criteria

* current methadone maintenance treatment program participation * medically necessary prescription opiate treatment (e.g., for chronic pain) * current criteria for a DSM-V diagnosis of substance dependence for sedative or hypnotic drugs, alcohol, stimulants, cocaine, inhalants, hallucinogens * diagnosis of organic brain disorder, bipolar disorder, schizophrenia, schizo-affective, schizophreniform or paranoid disorder * current suicidality on the Modified Scale for Suicidal Ideation * evidence of neuropsychological dysfunction as assessed by the study physician with confirmation with the Folstein Mini-Mental Status Examination• * anticipated major painful event (significant surgical procedure) in the coming 4 months * probation or parole requirements or an upcoming move that might interfere with protocol participation * history of allergic reaction to buprenorphine or naloxone * currently pregnant or planning to become pregnant in the next 4 months * history of neurological disorder (e.g., epilepsy, stroke, brain injury) * impaired uncorrected vision * FMRI contraindications (e.g., claustrophobia, specific metallic implants and injuries)

Design outcomes

Primary

MeasureTime frameDescription
Changes in Resting State Disorganization Between Baseline and One Week by Person by Lapsed CategoryBaseline and 1 weekThe measure of resting state organization is a z-value derived from Pearson's r-values. They represent the effect of the association between the brain activity of the seed region and each brain voxel over time during the resting state FMRI scan. A central z-value of 0 means that there is no association between the seed region and the voxel. Positive and negative z-values approaching 0 reflect increasingly weaker associations, and more extreme positive and negative values reflect stronger associations. Attributing the qualitative labels better or worse to these values depend upon the brain network and context. In many networks (eg, task-positive cognitive control network), a stronger positive correlation is thought to reflect better network organization. In the task-negative default mode network a stronger positive relationship is considered by some as worse. For this study, these are not yet used as clinical measures and there are not known cutoffs.
Working Memory - Between Groups at Baseline by Lapsed CategoryBaselinefMRI working memory differences between participants who lapse back to opioid use and those who don't
Changes in Working Memory - Within Groups During Satiation and WithdrawalBaseline and 1 weekfMRI working memory differences under satiation vs withdrawal from opioids

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
FMRI Suboxone FMRI: all participants will complete 2 FMRIs Suboxone: all participants will be prescribed Suboxone for 4 months during their study participation
19
Total19

Withdrawals & dropouts

PeriodReasonFG000
Overall Studydid not attend second fMRI1
Overall Studyruled out at screening1

Baseline characteristics

CharacteristicAll Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
19 Participants
Age, Continuous36.63 years
STANDARD_DEVIATION 7.05
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
White
14 Participants
Region of Enrollment
United States
19 Participants
Sex: Female, Male
Female
7 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 7
other
Total, other adverse events
0 / 120 / 7
serious
Total, serious adverse events
0 / 120 / 7

Outcome results

Primary

Changes in Resting State Disorganization Between Baseline and One Week by Person by Lapsed Category

The measure of resting state organization is a z-value derived from Pearson's r-values. They represent the effect of the association between the brain activity of the seed region and each brain voxel over time during the resting state FMRI scan. A central z-value of 0 means that there is no association between the seed region and the voxel. Positive and negative z-values approaching 0 reflect increasingly weaker associations, and more extreme positive and negative values reflect stronger associations. Attributing the qualitative labels better or worse to these values depend upon the brain network and context. In many networks (eg, task-positive cognitive control network), a stronger positive correlation is thought to reflect better network organization. In the task-negative default mode network a stronger positive relationship is considered by some as worse. For this study, these are not yet used as clinical measures and there are not known cutoffs.

Time frame: Baseline and 1 week

Population: Mean fMRI resting state disorganization at baseline among no-lapse and lapse groups

ArmMeasureGroupValue (MEAN)Dispersion
No LapseChanges in Resting State Disorganization Between Baseline and One Week by Person by Lapsed CategoryDMN synchrony active use0.315 Mean default mode network (DMN) z-scoresStandard Deviation 0.057
No LapseChanges in Resting State Disorganization Between Baseline and One Week by Person by Lapsed CategoryDMN synchrony abstinent0.384 Mean default mode network (DMN) z-scoresStandard Deviation 0.098
LapseChanges in Resting State Disorganization Between Baseline and One Week by Person by Lapsed CategoryDMN synchrony active use0.328 Mean default mode network (DMN) z-scoresStandard Deviation 0.076
LapseChanges in Resting State Disorganization Between Baseline and One Week by Person by Lapsed CategoryDMN synchrony abstinent0.394 Mean default mode network (DMN) z-scoresStandard Deviation 0.139
Primary

Changes in Working Memory - Within Groups During Satiation and Withdrawal

fMRI working memory differences under satiation vs withdrawal from opioids

Time frame: Baseline and 1 week

Population: Within-group analyses contrasting two fMRI responses

ArmMeasureGroupValue (MEAN)Dispersion
No LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in R middle frontal gyrus0.35 % fMRI signal changeStandard Deviation 0.3
No LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in R inferior parietal lobule0.33 % fMRI signal changeStandard Deviation 0.29
No LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in L inferior parietal lobule0.47 % fMRI signal changeStandard Deviation 0.43
No LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in bilateral supplementary motor0.34 % fMRI signal changeStandard Deviation 0.27
LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in bilateral supplementary motor0.35 % fMRI signal changeStandard Deviation 0.22
LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in R middle frontal gyrus0.37 % fMRI signal changeStandard Deviation 0.25
LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in L inferior parietal lobule0.54 % fMRI signal changeStandard Deviation 0.32
LapseChanges in Working Memory - Within Groups During Satiation and WithdrawalMean Brain Response in R inferior parietal lobule0.42 % fMRI signal changeStandard Deviation 0.22
Primary

Working Memory - Between Groups at Baseline by Lapsed Category

fMRI working memory differences between participants who lapse back to opioid use and those who don't

Time frame: Baseline

Population: Mean fMRI working memory response at baseline among no-lapse and lapse groups

ArmMeasureGroupValue (MEAN)Dispersion
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (c)0.39 % fMRI signal changeStandard Deviation 0.22
No LapseWorking Memory - Between Groups at Baseline by Lapsed Categorybilateral SMA0.45 % fMRI signal changeStandard Deviation 0.14
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR middle frontal gyrus0.39 % fMRI signal changeStandard Deviation 0.15
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR inferior parietal lobule0.34 % fMRI signal changeStandard Deviation 0.14
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL inferior parietal lobule0.36 % fMRI signal changeStandard Deviation 0.14
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (a)0.46 % fMRI signal changeStandard Deviation 0.2
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (b)0.36 % fMRI signal changeStandard Deviation 0.16
No LapseWorking Memory - Between Groups at Baseline by Lapsed Categorybilateral precuneus0.38 % fMRI signal changeStandard Deviation 0.2
No LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR anterior insula0.42 % fMRI signal changeStandard Deviation 0.14
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR anterior insula0.39 % fMRI signal changeStandard Deviation 0.26
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (a)0.49 % fMRI signal changeStandard Deviation 0.26
LapseWorking Memory - Between Groups at Baseline by Lapsed Categorybilateral SMA0.42 % fMRI signal changeStandard Deviation 0.27
LapseWorking Memory - Between Groups at Baseline by Lapsed Categorybilateral precuneus0.37 % fMRI signal changeStandard Deviation 0.26
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR middle frontal gyrus0.40 % fMRI signal changeStandard Deviation 0.23
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (b)0.33 % fMRI signal changeStandard Deviation 0.25
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryR inferior parietal lobule0.33 % fMRI signal changeStandard Deviation 0.24
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL middle frontal gyrus (c)0.36 % fMRI signal changeStandard Deviation 0.28
LapseWorking Memory - Between Groups at Baseline by Lapsed CategoryL inferior parietal lobule0.32 % fMRI signal changeStandard Deviation 0.25

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026